Synthetic Surgical Glove Market - Forecasts from 2024 to 2029

Synthetic Surgical Glove Market - Forecasts from 2024 to 2029

The synthetic surgical glove market is projected to witness a CAGR of 9.15% during the forecast period to reach a total market size of US$3,327.646 million by 2029, up from US$1,803.042 million in 2022.

Synthetic surgical gloves, which are made of synthetic polymers such as nitrile and neoprene, are utilized amid surgeries to avoid defilement of the specialist, surgeons, and the patient. These are disposable gloves that offer hypoallergenic properties, superior chemical resistance, strength, and great material affectability, making them reasonable for different medical methods. They are accessible in powder-free choices to decrease powder-related complications. The developing predominance of constant illnesses and changes in the way of life around the globe are considered the key drivers for the manufactured surgical gloves industry expansions.

Another major variable is the increasing latex hypersensitivity among healthcare specialists. Allergies can bother not only healthcare personnel but also patients. Allergy development is less likely when synthetic surgical gloves are worn. The utilization of these gloves is profitable as they are safer to friction and low wear than other gloves.

The synthetic surgical gloves market has increased due to rising awareness of latex hypersensitivities, the inclination for hypoallergenic options, and the requirement for advanced and progressed features. Individual defensive equipment has gotten to be indeed more significant in light of the COVID-19 flare-up. Market flow may shift based on prominent regulatory standards, geographical regions, and innovative technological progressions in the manufacturing of these gloves.

Market Drivers:

Increasing patient numbers is predicted to propel the synthetic surgical glove market growth.

Iin September 2023, the World Health Organization(WHO) released data on Non-Communicable Diseases (NCDs) which stated that 74% of all deaths globally are due to NCDs which is equivalent to 41 million people every year out of which about 17.9 million people die each year from Cardiovascular disease which is accounts as the most death-causing disease globally. This shows that there will be a constant upward movement of patients suffering from major chronic diseases like diabetes, high blood pressure, cardiovascular disease, high cholesterol, and cancer, amongst others.

In addition to that rise, some other non-communicable diseases such as cancer, respiratory diseases, and diabetes are the diseases due to which the number of patients has increased. According to WHO, deaths Caused due to these diseases are 9.3 million, 4.1 million, and 1.5 million, respectively.

Moreover, the increasing number of older age people is also further augmenting the rising number of patients. According to Population Reference Bureau survey data from March 2020, the worlds oldest populations that are aged 65 and more are in Asia and Europe, the next oldest population is 28 percent in Japan, and Italy comes after with 23 percent whereas Greece, Portugal, and Finland make up the final five places, each with a little less than 22% of the older population. Further, countries of Southern Europe, consisting of Croatia, Greece, Italy, Portugal, Serbia, Spain, Slovenia, and Malta with 21% of the population aged 65+ are considered the oldest region. Further, the increasing medical tourism is also being observed for surgery purposes which will also have a positive impact on the market.

Rising latex allergy among healthcare workers could promote the demand for synthetic surgical gloves globally

A primary driver of the worldwide synthetic surgical glove market is the increasing incidence of latex allergy among medical professionals. Allergies to latex are hypersensitivity responses to proteins found in natural rubber latex, which is frequently used to make latex gloves. Due to extended exposure, healthcare workers—including physicians, nurses, and laboratory personnel—are more likely to acquire these allergies. These allergies can cause hypersensitivity reactions that are either immediate or delayed, resulting in symptoms including hives, itching, and anaphylaxis.

Healthcare professionals should use synthetic surgical gloves in order to emphasize patient safety and avoid cross-contamination. Facilities may also decide to use synthetic gloves in order to meet legal standards and protect the health and safety of their employees.

Although wearing latex might cause allergic reactions, healthcare workers who use these gloves can help stop the spread of many infectious diseases. When it comes into touch with latex, it can get blisters, eczema, rashes, redness, itching, and swelling. Furthermore, increased regular interaction with latex has been linked to a substantial risk of developing a latex allergy.

Further,in recent years, the number of documented occurrences of such responses across the healthcare industry has increased. According to the American Latex Allergy Association, natural rubber latex sensitization affects 8-17 percent of healthcare professionals in the United States. As a result, several hospitals throughout the world have begun using synthetic (non-latex) medical gloves.

Market Restraints:

The high cost of raw materials could hinder the synthetic surgical glove market in the future.

The primary expenditure is on raw materials for manufacturing synthetic surgical gloves. Nitrite is one of the popular raw elements used in the product's manufacture, followed by polyisoprene and neoprene. The nitrile material is a substitute for natural rubber and has properties similar to latex material. Also, the price of gloves is determined by the raw ingredient, such as nitrite, which is used to eliminate the risk of allergy. The quality of the raw material cannot be hindered as it will impact the strength, thickness, flexibility, and infection transmission, ruining the purpose of wearing gloves. Authority rules have also been imposed on the sector to ensure that the gloves are of a consistent quality.

Key Developments:

May 2023- Ansell, the world's top provider of surgical gloves, has been awarded the highest recyclability certification by Institut Cyclos-HTP (CHI), confirming an AAA rating for the SMART Pack™ packaging for surgical gloves, a globally recognized organization that assesses and certifies packaging and goods.
September 2022- A global partnership was announced by Ansell and Chemwatch in order to improve chemical safety. Their goal also involves raising awareness about the risks and consequences of exposure to hazardous chemicals. It leverages mutual chemical safety advice and utilizes the Chemwatch SDS database to support AnsellGUARDIAN® Chemical Technical Experts in recommending appropriate PPE for specific hazards and safety needs.
August 2022- Minco Wholesale & Supply Inc. partnered with Canadian manufacturer Supermax Healthcare Canada Group to offer its renowned disposable protective product line, Aurelia®. The partnership enhances Minco Supply's selection of quality products and supplies to clients in the healthcare, agriculture, industrial, and hospitality sectors. Popular products include exam-grade nitrile, vinyl and latex gloves, non-woven & cotton medical products, protective apparel, and protective masks. The partnership positions Minco Supply as a lead supplier in the Canadian marketplace, offering disposable protective gloves suitable for all industries.

Key Market Segmentation:

Synthetic Surgical Glove Market is segmented and analyzed as below:

By Material
Polyisoprene (PI)
Neoprene
Nitrile
By End-User
Hospitals
Medical Centers
Ambulatory Surgical Centers
By Geography
North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Spain
Others
Middle East and Africa
Saudi Arabia
Israel
Others
Asia Pacific
China
Japan
India
South Korea
Others